The Impact of Alcohol Abuse on Health
Defining Alcohol Intoxication and the Broader Concept of Health
In order for a person to be considered under the influence of alcohol, their blood alcohol concentration must exceed the legally defined limits — that is, 0.50 grams per liter of blood (calculated by blood sampling) or 0.25 milligrams per liter of exhaled air (using a breathalyzer). Once these thresholds are breached, ethyl alcohol acts as a general depressant on the central nervous system, entering the body and distributing itself throughout all fluids, tissues, and muscles — including the brain — setting in motion a cascade of physiological impairments that extend far beyond simple intoxication.
Yet understanding what alcohol truly damages requires first understanding what "health" actually means. According to the Constitution of the World Health Organization (1946), health is "a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity." This foundational definition makes clear that health is not simply the opposite of illness; it is a multidimensional phenomenon shaped by a complex interplay of social, economic, cultural, environmental, and behavioral factors. Among these behavioral determinants, alcohol consumption occupies a particularly significant place, with research consistently demonstrating that high alcohol consumption is more prevalent among individuals in lower socio-professional categories — a pattern that underscores the deep entanglement of substance use with socioeconomic disadvantage, inequality of access to healthcare, and structural vulnerability.
The scale of alcohol's impact on global health is staggering. According to the WHO's 2024 Global Status Report on Alcohol and Health, an estimated 400 million people aged 15 years and older worldwide live with alcohol use disorders, and approximately 209 million of those live with alcohol dependence. In 2019, 2.6 million deaths were directly attributable to alcohol consumption, accounting for 4.7% of all global deaths — with 2 million of those deaths occurring among men. From a disease burden perspective, the WHO estimates that alcohol plays a causal role in more than 200 diseases, injuries, and other health conditions, though the available scientific evidence allows quantification of the burden for only 31 specific conditions. Globally, worldwide total alcohol consumption in 2022 was equivalent to 5.0 liters of pure alcohol per person aged 15 years or older, with the WHO European Region recording the highest regional average at 9.2 liters per capita — nearly double the global figure.
The Physiology of Alcohol: How Ethanol Ravages the Body
As a component of alcoholic beverages, ethyl alcohol is absorbed primarily through the stomach and small intestine and rapidly distributes throughout the body. Its pharmacological action as a central nervous system depressant stems from its interaction with neurotransmitter systems — primarily by enhancing gamma-aminobutyric acid (GABA) inhibition, which produces the initial euphoric and sedative effects that drinkers seek. However, chronic alcohol exposure disrupts this system profoundly. Prolonged use leads to GABA receptor downregulation and increased glutamate excitability, creating an imbalance that impairs prefrontal executive function while reinforcing reward circuits in the nucleus accumbens and amygdala. This neuroadaptation is what drives compulsive drinking behavior and makes alcohol dependence so difficult to overcome.
Beyond its effects on the brain, alcohol damages virtually every organ system. The liver bears the greatest burden, as it is the primary organ responsible for metabolizing ethanol. Chronic alcohol consumption produces a well-characterized spectrum of liver disease: beginning with fatty liver (hepatic steatosis), progressing through alcoholic hepatitis, and culminating in cirrhosis — the final, irreversible stage marked by extensive fibrosis, hepatocyte degeneration, and the formation of regenerative nodules that ultimately lead to liver failure. Research published in the Journal of Hepatology in 2023 confirmed that alcohol increases the risk of liver disease-related mortality 260-fold, while also raising cardiovascular mortality by 3.2-fold and cancer mortality by 5.1-fold. Globally, alcohol is the leading cause of cirrhosis and is responsible for nearly 60% of cirrhosis cases in Europe, North America, and Latin America. Approximately 35% of patients with alcohol use disorder will develop some form of alcohol-associated liver disease.
The trajectory of alcohol-related liver disease in the United States illustrates the escalating severity of this crisis. Between 1999 and 2019, deaths from alcoholic cirrhosis — the final, irreversible phase of alcoholic liver disease — increased more than threefold. During the period from 2010 to 2016, alcohol-related liver disease became the primary cause of nearly one in three liver transplants in the United States, surpassing hepatitis C as the leading indication for transplantation. Particularly alarming is the age distribution of these deaths: the largest increase — sevenfold — was observed among young adults aged 25 to 34, while in 2019 the proportion of alcohol-related cirrhosis deaths was highest (80.9%) among decedents in that same age group. Modeling studies published in The Lancet Public Health project that without substantial changes in drinking culture or interventions targeting high-risk drinking, approximately one million individuals in the United States could die from alcohol-related liver disease between 2019 and 2040.
Alcohol, Cancer, and Chronic Disease
It is an indisputable fact that alcohol dependence causes disease, disability, and premature death. According to the WHO, more than 60 types of conditions and chronic diseases are attributed to excessive alcohol consumption. Among the most devastating is cancer. The International Agency for Research on Cancer (IARC) classifies ethanol in alcoholic beverages as a Group 1 carcinogen — the highest level of certainty. In 2019, 4.4% of all cancers diagnosed globally and 401,000 cancer deaths were attributable to alcohol consumption.
Since 2007, the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research have documented the increased likelihood of developing certain cancers due to alcohol use, focusing their recommendations on reducing consumption as a preventive measure. Specifically, cancers of the larynx, esophagus, liver, stomach, breast, and colorectal region are directly associated with alcohol abuse. In men, the highest alcohol-attributable cancer rate is found in cancers of the upper respiratory and digestive tracts; in women, breast cancer carries the strongest association. The European Prospective Investigation into Cancer and Nutrition (EPIC) study, conducted across ten European countries with a large participant base, further corroborated these findings, documenting a strong correlation between alcohol consumption and overall mortality — characterizing alcohol abuse as an independent determinant of mortality from alcohol-related cancers (ARCs).
The relationship between alcohol and cardiovascular disease is equally concerning. While moderate alcohol consumption has historically been thought to confer some cardiovascular protection — reducing risks of myocardial infarction under certain conditions — this so-called "cardioprotective effect" has been increasingly challenged by modern research methodologies. The WHO reported that in 2019, an estimated 474,000 deaths from cardiovascular diseases were attributable to alcohol consumption. Critically, rates of heart attack and stroke, as well as hypertension and hemorrhagic stroke, begin to rise above one drink daily, especially in women. The ancient Latin maxim abusus non tollit usum (abuse does not negate use) notwithstanding, the overall net effect of alcohol consumption is considered harmful to health, and its consumption should not be recommended as a preventive strategy against cardiovascular disease.
Furthermore, smoking is closely linked to alcohol abuse as a contributing risk factor, particularly for cancers of the upper respiratory system. The synergistic interaction between alcohol and tobacco creates a multiplicative — rather than merely additive — cancer risk, making the combination particularly lethal for the oral cavity, pharynx, larynx, and esophagus.
Neuropsychiatric Disorders and Mental Health
Among alcohol-related conditions, neuropsychiatric disorders account for approximately one-third of the total disease burden attributable to alcohol. The bidirectional relationship between alcohol use and mental health disorders — particularly depression and anxiety — represents one of the most clinically significant and therapeutically challenging dimensions of alcohol abuse.
Community-based epidemiological surveys consistently demonstrate that having an alcohol use disorder at least doubles the odds of developing depressive, anxiety, and other non-substance-use disorders. Meta-analytic evidence confirms that individuals with common mental disorders — including depression, anxiety, and phobia — face a twofold increase in the odds of developing an alcohol use disorder compared to those without such conditions. This relationship is cyclical: alcohol misuse may serve as a maladaptive coping mechanism for pre-existing depression and anxiety, while chronic consumption simultaneously precipitates or worsens these mental health conditions over time through neurotransmitter disruption, alterations in stress response pathways, and structural brain changes in regions responsible for emotional regulation and reward processing.
Research from the University of Minnesota Medical School, published in Alcohol: Clinical & Experimental Research, revealed a phenomenon termed the "harm paradox" — wherein individuals with anxiety and major depressive disorder experience more severe alcohol use disorder symptoms than those without such conditions, even at identical levels of drinking. Approximately 20–40% of people with an internalizing disorder (such as anxiety or depression) develop alcohol use disorder, compared to roughly 5% of the general population. Alcohol use disorder is now recognized as the second most prevalent mental disorder globally, following depression, underscoring their deeply intertwined nature.
Abrupt cessation or reduction of alcohol use further compounds psychological risk, as withdrawal triggers acute stress responses in the brain that lead to sudden increases in anxiety and depression. Long-term neurocognitive changes resulting from chronic alcohol exposure — including impaired memory, diminished executive function, and degradation of prefrontal cortical integrity — can persist well beyond the period of active drinking, creating lasting vulnerability to depressive relapse and cognitive decline. Data from the United States covering the period 1999 to 2023 show that mortality from alcohol-induced neurological and psychiatric conditions has followed a persistent upward trend, peaking during the COVID-19 pandemic — a period when pandemic-related psychosocial stressors, relaxed alcohol policies (including home delivery and to-go drinks), and widespread social isolation drove many individuals to adopt alcohol consumption as a coping mechanism.
Alcohol's Impact on Public Health and Safety
Beyond its effects on individual health, alcohol abuse exerts a devastating toll on public health and safety. Traffic accidents caused by driving under the influence of alcohol represent one of the most visible and lethal consequences. In 2019, of a total of 298,000 deaths from alcohol-related road crashes, 156,000 were caused by someone other than the person who was drinking — a stark reminder that alcohol's harm extends far beyond the drinker. Other injury categories include falls, drowning, burns, sexual assault, intimate partner violence, and suicide.
In the WHO European Region alone, alcohol was responsible for nearly one in every three injury-related deaths in 2019, including 42% of all homicides, 37% of suicides, and 35% of road traffic fatalities. These figures transform alcohol from a personal health issue into a critical public safety concern with profound societal implications.
Globally, 23.5% of all young people aged 15–19 were current drinkers as of 2019, with the highest rates in Europe (45.9%) and the Americas (43.9%). Early initiation of alcohol use is associated with worsened mental health outcomes — including anxiety and cognitive decline — as well as higher consumption levels in adulthood, creating a generational cycle of alcohol-related harm. Among 11-year-olds across OECD countries, the share reporting alcohol consumption rose slightly from 4% to 5% between 2018 and 2022, with the highest rates among children (10% or more) observed in the Czech Republic, France, Hungary, Bulgaria, and Romania.
Alcohol consumption during pregnancy represents yet another dimension of public health harm, increasing the risk of fetal alcohol spectrum disorders (FASDs) — the most severe form of which, fetal alcohol syndrome (FAS), is associated with developmental disabilities and birth defects. A causal relationship has also been established between alcohol use and the incidence or outcomes of infectious diseases such as tuberculosis and HIV.
The Mediterranean Paradox: Alcohol in Greece
In Greece, alcohol consumption is deeply embedded in the Mediterranean lifestyle — a cultural context that, while associated with certain dietary health benefits, can paradoxically lead to the underdiagnosis of alcohol abuse. Wine and spirits are woven into social rituals, family gatherings, and everyday meals, creating an environment in which problematic drinking may go unrecognized or be normalized as tradition.
Yet the data paint a more nuanced picture. Greece records the lowest per capita alcohol consumption in the European Union — approximately 6.6 liters of pure alcohol per person in 2023, according to the OECD's Health at a Glance 2025report, well below the EU average of 8.5 liters. World Bank data show that Greece's total per capita consumption declined from 8.7 liters in 2010 to 5.8 liters by 2020, representing one of the largest reductions in the EU during that period. Furthermore, over 35% of the Greek population reported in 2022 that they never consume alcohol — one of the highest rates of abstinence in the European Union.
However, these relatively encouraging aggregate figures mask a concerning pattern: Greece, alongside Ireland and Sweden, reports among the highest rates of monthly binge drinking in the OECD, with more than 40% of individuals engaging in heavy episodic drinking at least once per month. This pattern — relatively low overall consumption combined with high rates of intense, concentrated drinking episodes — is particularly dangerous from a health perspective, as binge drinking is associated with acute cardiovascular events, alcohol poisoning, and heightened risk of accidents and violence.
The EPIC study's gradient findings — showing a descending pattern of alcohol consumption from northern to southern Europe, with Greece and Spain having the highest percentages of populations that had either never consumed alcohol or were former users, while Denmark and Germany had the highest proportions of active consumers — reflect these cultural and regional nuances. The degree and pattern of consumption vary significantly, underscoring that a one-size-fits-all approach to alcohol policy is inadequate.
Genetics, Heredity, and Individual Susceptibility
Although studies have demonstrated that the habit of drinking alcohol has a hereditary basis, the genetic architecture of alcohol dependence remains incompletely understood. Research has identified several genes associated with alcohol metabolism and susceptibility — including well-characterized variants of the alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) gene families, which influence how efficiently the body processes ethanol. However, only a limited number of genetic loci have been identified as significantly associated with alcohol consumption at a population level, and therefore the etiology of alcoholism cannot be explained solely on a genetic basis.
Gene-environment interactions play a crucial role. Studies examining genetic polymorphisms — such as the MVP rs4788186 variant — in relation to alcohol withdrawal and depression have demonstrated that developmental plasticity varies among individuals, with specific allele variations moderating the relationship between alcohol dependence and psychiatric outcomes. Epigenetic research has further revealed that chronic alcohol exposure induces lasting changes in gene expression through mechanisms such as DNA methylation and histone modification, particularly in brain regions associated with reward processing and stress response. These findings suggest that while genetic predisposition creates vulnerability, environmental factors — including socioeconomic status, early life adversity, and cultural context — ultimately determine whether that vulnerability manifests as clinical addiction.
The Economic Burden of Alcohol Abuse
The societal cost of alcohol abuse extends well beyond healthcare expenditures. In high-income countries, alcohol-related harm is estimated to cost approximately 2.6% of gross domestic product — a figure that encompasses direct medical costs, criminal justice expenses, lost economic productivity due to absenteeism and premature mortality, and social services. In the EU, the economic cost of deaths from alcohol-attributable cancers alone was estimated at nearly €5 billion in 2018, representing approximately 10% of the total cost of all cancer deaths in the region. In the United Kingdom, a 2024 analysis by the Institute of Alcohol Studies found costs of £27.4 billion annually — a more than 40% increase from the same methodology applied in 2003. In Germany, the annual economic burden reaches €57 billion, while government revenue from alcohol taxation covers only a fraction — approximately €3.2 billion.
These costs are not borne equally. The death rates from alcohol consumption per liter consumed are highest in low-income countries and lowest in high-income countries, reflecting disparities in healthcare access, nutritional status, and the prevalence of co-occurring risk factors. The economic costs include healthcare for over 200 alcohol-attributable conditions, criminal justice processing for alcohol-fueled violence, and the lost productive capacity of millions of working-age individuals whose premature disability or death removes them from the labor force.
Notably, the global alcohol industry itself is undergoing a structural transformation. A Bloomberg index tracking roughly 50 of the world's largest beer, wine, and spirits producers shows that the industry has lost approximately $830 billion in market value over the past four years — a 46% collapse from its June 2021 peak — driven in large part by declining consumption among younger generations. A 2025 Gallup survey found U.S. alcohol consumption at its lowest level since tracking began in 1939, with only 54% of American adults reporting that they drink. This generational shift, propelled by rising health consciousness and increased awareness of alcohol's health risks, is reshaping both the commercial landscape and the public health calculus.
Policy Interventions: A Multifactorial Approach
Following the extensive body of research documenting alcohol's devastation — including findings reflected in studies such as Mentis (2024), who examined the impact of health determinants on Greek health levels as a capture of the health production function — there is an urgent need to address the problem of alcoholism through comprehensive, multifactorial policy interventions.
The World Health Organization's SAFER initiative, launched in 2018 and expanded through the Global Alcohol Action Plan 2022–2030, outlines five high-impact, cost-effective strategies that form the foundation of evidence-based alcohol control:
Strengthen restrictions on alcohol availability. Enacting and enforcing restrictions on the commercial and public availability of alcohol through laws, policies, and programs — including limiting hours and density of alcohol retail outlets — prevents easy access, particularly among young people and other vulnerable populations.
Advance and enforce drink-driving countermeasures. Road users impaired by alcohol face a significantly elevated crash risk. Strong drink-driving laws, low blood alcohol concentration limits, sobriety checkpoints, and random breath testing — such as the recent initiative by the Thessaloniki Pharmaceutical Association and the Thessaloniki Traffic Police, which freely distributed easy-to-use and reliable self-tests for detecting alcohol in drivers' breath — are essential tools for road safety. Such community-level interventions enhance public awareness while providing practical means for individuals to monitor their own alcohol levels, thereby promoting both personal responsibility and broader societal safety.
Facilitate access to screening, brief interventions, and treatment. Health professionals have a critical role in helping individuals reduce or cease drinking to minimize health risks. At the clinical level, pharmacological treatments such as disulfiram (which produces aversive reactions to alcohol consumption), naltrexone (which blocks opioid receptors involved in alcohol's rewarding effects), and acamprosate (which helps restore neurochemical balance in the abstinent brain) provide essential therapeutic options. However, treatment must be individualized, taking into account psychological, economic, and genetic factors that influence clinical symptom variation. Studies of integrated interventions combining cognitive-behavioral therapy with motivational interviewing have demonstrated significant reductions in both alcohol consumption and the severity of comorbid depressive and anxiety symptoms. Despite the availability of effective treatments, treatment coverage remains critically low globally — ranging from less than 1% to no more than 35% across countries reporting data — with stigma, discrimination, and misconceptions about treatment efficacy contributing to these gaps.
Enforce bans or comprehensive restrictions on alcohol advertising, sponsorship, and promotion. Enacting comprehensive marketing restrictions — particularly in the digital sphere — protects children, adolescents, and abstainers from commercial pressure to start consuming alcohol. The alcohol industry's ongoing interference in policy development, reported by countries worldwide, underscores the necessity of protecting public health measures from commercial interests.
Raise prices on alcohol through excise taxes and pricing policies. Of all alcohol policy measures, the evidence is strongest that pricing affects consumption. Alcohol taxation and pricing policies are among the most effective and cost-effective alcohol control strategies available. Price increases delay initiation of alcohol use among young people, slow progression toward heavier consumption, and reduce heavy episodic drinking — all while generating government revenue that can offset the economic costs of alcohol-related harm. A November 2025 policy guidance document from the RESET Alcohol initiative, in collaboration with the WHO and Johns Hopkins Bloomberg School of Public Health, outlined six core principles for effective alcohol excise taxation, emphasizing that taxes should be based on ethanol content, applied consistently across beverage types, and increased regularly to maintain reduced affordability.
Health as a Primary Investment
Given that health is a primary investment — one that catalytically improves the standard of living of a population while simultaneously increasing the productive capacity of the individuals who compose it — expenditure on alcohol prevention and treatment must be understood as productive, not merely remedial. Investment in this sector, assessed through specific health indicators and economic metrics, promotes individual quality of life and, consequently, the broader socioeconomic development of the population.
The convergence of evidence — from the WHO's global mortality data to EPIC's cancer epidemiology, from the escalating liver disease crisis documented in the United States to the neuropsychiatric research revealing alcohol's permanent neurological toll — points unequivocally toward the necessity of immediate, coordinated, and sustained action. By implementing the proposed measures — including comprehensive national and local prevention policies, behavior management strategies that create conditions favoring healthy lifestyles, psychological support for alcohol-dependent individuals, individualized pharmacological treatment when necessary, taxation and pricing reform, and marketing restrictions — public health authorities can meaningfully reduce the prevalence of alcohol abuse.
The challenge is both urgent and surmountable. With nearly half a billion people globally affected by alcohol use disorders, with 2.6 million lives lost annually, and with the economic costs reaching into hundreds of billions of dollars, the case for action is beyond dispute. By thoroughly informing society about the negative effects of alcoholism on health, by protecting public health policy from commercial interference, and by investing in the full spectrum of prevention, screening, and treatment, it is possible to reverse the tide of alcohol-related harm — improving health, enhancing productivity, and advancing the quality of life for individuals and communities worldwide.